SEC Form 4 filed by President, Glbl Ind. Coatings Bowes Timothy Earl Joseph

$AXTA
Paints/Coatings
Consumer Discretionary
Get the next $AXTA alert in real time by email
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bowes Timothy Earl Joseph

(Last) (First) (Middle)
1050 CONSTITUTION AVENUE

(Street)
PHILADELPHIA PA 19112

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Axalta Coating Systems Ltd. [ AXTA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Glbl Ind. Coatings
3. Date of Earliest Transaction (Month/Day/Year)
01/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 2,354 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 01/27/2025 A 4,034 (2) (2) Common Shares 4,034 $0 4,034 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one common share of Axalta Coating Systems Ltd.
2. This restricted stock unit grant vests in two equal annual installments beginning on the first anniversary of the grant date.
Remarks:
/s/ Mark Sherman, attorney-in-fact 01/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Get the next $AXTA alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AXTA

DatePrice TargetRatingAnalyst
1/17/2025$41.00Peer Perform → Outperform
Wolfe Research
12/18/2024$45.00 → $41.00Buy → Neutral
Citigroup
12/17/2024Overweight → Sector Weight
KeyBanc Capital Markets
11/13/2024$47.00Outperform
Evercore ISI
3/1/2024Peer Perform
Wolfe Research
1/8/2024$35.00 → $36.00Buy → Neutral
UBS
6/14/2023$37.00Buy
Citigroup
2/17/2023$30.00 → $36.00Sector Perform → Outperform
RBC Capital Mkts
More analyst ratings

$AXTA
Press Releases

Fastest customizable press release news feed in the world

See more
  • Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

    Expanded executive team to support operational excellence and commercialization of the CellFX nanosecond PFA Platform Pulse Biosciences, Inc. (NASDAQ:PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced the appointment of Jon Skinner as Chief Financial Officer, effective February 3, 2025. "I am excited to announce Jon as our next CFO, further building upon our momentum at Pulse Biosciences. His experience as a financial leader at both growth stage and scaled public diversified medtech companies will be extremely valuable in our efforts to advance our nanosecon

    $AXTA
    $PLSE
    $TFX
    Paints/Coatings
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care
  • Axalta Releases Fourth Quarter and Full Year 2024 Results

    PHILADELPHIA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta"), a leading global coatings company, announced its financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Highlights Record fourth quarter net sales of $1.3 billionNet income increased 85% year over year to $137 million, with net income margins of 10.5%, a year over year improvement of 480 basis pointsRecord fourth quarter Adjusted EBITDA of $275 millionAdjusted EBITDA margin improved 170 basis points year over yearDiluted EPS increased 91% to $0.63 and Adjusted Diluted EPS increased 30% to $0.60 Fiscal Year 2024 Highlights Record full year net

    $AXTA
    Paints/Coatings
    Consumer Discretionary
  • Axalta Wins a 2025 BIG Innovation Award

    PHILADELPHIA, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems (NYSE:AXTA), a leading global coatings company, today announced that its Voltatex® 8537PF won the 2025 BIG Innovation Award presented by the Business Intelligence Group (BIG). The annual business awards program recognizes organizations, products and people that bring new ideas to life in innovative ways. "Innovation is at the core of what we do and receiving this BIG Innovation Award yet again is a testament to this." said Robert K. Roop, Senior Vice President and Chief Technology Officer at Axalta. "Our Voltatex® 8537PF improves the reliability and efficiency of electric vehicles by addressing key requirements that ha

    $AXTA
    Paints/Coatings
    Consumer Discretionary

$AXTA
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$AXTA
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$AXTA
SEC Filings

See more

$AXTA
Leadership Updates

Live Leadership Updates

See more
  • Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

    Expanded executive team to support operational excellence and commercialization of the CellFX nanosecond PFA Platform Pulse Biosciences, Inc. (NASDAQ:PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced the appointment of Jon Skinner as Chief Financial Officer, effective February 3, 2025. "I am excited to announce Jon as our next CFO, further building upon our momentum at Pulse Biosciences. His experience as a financial leader at both growth stage and scaled public diversified medtech companies will be extremely valuable in our efforts to advance our nanosecon

    $AXTA
    $PLSE
    $TFX
    Paints/Coatings
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care
  • Axalta Appoints Tim Bowes as President, Global Industrial Coatings

    PHILADELPHIA, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta" or the "Company"), a leading global coatings company, today announced that Tim Bowes has been appointed President, Global Industrial Coatings, effective January 27, 2025. Mr. Bowes will succeed Shelley Bausch who will be stepping down from her role. Most recently, Mr. Bowes served as Axalta's Senior Vice President and Chief Transformation Officer. Prior to joining Axalta, he served as Senior Vice President and President of Electrification, Industrial, Aftermarket, Purchasing & Supply Chain for Meritor. Mr. Bowes has also served as Senior Vice President and President of the Casting business un

    $AXTA
    Paints/Coatings
    Consumer Discretionary
  • Axalta Appoints Chris Evans Vice President, Global Strategy, and Colleen Lubic Vice President, Investor Relations

    PHILADELPHIA, July 08, 2024 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA), a leading global coatings company, today announced that Chris Evans has been appointed Vice President, Global Strategy and Colleen Lubic has been appointed Vice President, Investor Relations. The appointments are effective immediately and further demonstrate Axalta's bench strength. Evans has served as Axalta's VP, Investor Relations since early 2022. Prior to joining the company, he led the Investor Relations function for Ecovyst and was Director of Investor Relations and Corporate Strategy for Chemours. He also covered the U.S. chemical industry for more than four years as a sell-side equity analyst

    $AXTA
    Paints/Coatings
    Consumer Discretionary

$AXTA
Financials

Live finance-specific insights

See more
  • Axalta Releases Fourth Quarter and Full Year 2024 Results

    PHILADELPHIA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta"), a leading global coatings company, announced its financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Highlights Record fourth quarter net sales of $1.3 billionNet income increased 85% year over year to $137 million, with net income margins of 10.5%, a year over year improvement of 480 basis pointsRecord fourth quarter Adjusted EBITDA of $275 millionAdjusted EBITDA margin improved 170 basis points year over yearDiluted EPS increased 91% to $0.63 and Adjusted Diluted EPS increased 30% to $0.60 Fiscal Year 2024 Highlights Record full year net

    $AXTA
    Paints/Coatings
    Consumer Discretionary
  • Axalta Schedules Fourth-Quarter and Full-Year 2024 Earnings Conference Call

    PHILADELPHIA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems (NYSE:AXTA), a leading global coatings company, will release its fourth-quarter and full-year 2024 financial results at 6 a.m. ET on Tuesday, February 4. The release and supporting materials will be posted to Axalta's Investor Relations site. In addition, the company will host a conference call at 8 a.m. ET on February 4. Chris Villavarayan, Chief Executive Officer and President, and Carl Anderson, Senior Vice President and Chief Financial Officer, will review the company's financial performance for the periods. A live webcast of the conference call will be available here. A replay of the webcast will be posted shortly

    $AXTA
    Paints/Coatings
    Consumer Discretionary
  • Axalta Releases Third Quarter 2024 Results

    PHILADELPHIA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta"), a leading global coatings company, announced its financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights: Record third quarter net sales of $1.32 billionNet income increased 40% year over year to $102 million; net income margin of 7.7%Record third quarter Adjusted EBITDA of $291 millionAdjusted EBITDA margin improved 220 basis points year over year to 22.1%Diluted EPS increased 39% year over year to $0.46 and Adjusted Diluted EPS increased 31% year over year to $0.59Repurchased $50 million of common shares Third Quarter 2024 Consolidated Financial R

    $AXTA
    Paints/Coatings
    Consumer Discretionary

$AXTA
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more